What is the appropriate treatment regimen for preseptal cellulitis, including adult and pediatric dosing, and alternatives for patients with penicillin allergy?

Treatment of Preseptal Cellulitis

For uncomplicated preseptal cellulitis, treat with oral cephalexin 500 mg four times daily in adults or 25-50 mg/kg/day divided into 4 doses in children, or oral amoxicillin-clavulanate 875/125 mg twice daily in adults or 25 mg/kg/day (amoxicillin component) in 2 divided doses in children. 1

Antibiotic Selection Algorithm

For Mild Cases (Outpatient Treatment)

First-line options:

• Cephalexin: 500 mg four times daily (adults) or 25-50 mg/kg/day in 4 divided doses (children) 1
• Amoxicillin-clavulanate: 875/125 mg twice daily (adults) or 25 mg/kg/day in 2 divided doses (children) 1
• Dicloxacillin: 500 mg four times daily (adults) or 25-50 mg/kg/day in 4 divided doses (children) - oral agent of choice for MSSA in adults 1

These regimens target the most common pathogens: Staphylococcus aureus (methicillin-susceptible) and Streptococcus species.

For Moderate to Severe Cases (Requiring Hospitalization)

Intravenous therapy is indicated when:

• Systemic signs of infection present (fever, tachycardia, elevated WBC)
• Failed outpatient treatment
• Concern for deeper infection or orbital involvement
• Poor adherence anticipated 1

IV antibiotic regimens:

• Nafcillin or oxacillin: 1-2 g every 4 hours IV (adults) or 100-150 mg/kg/day in 4 divided doses (children) - parenteral drug of choice for MSSA 1
• Cefazolin: 1 g every 8 hours IV (adults) or 50 mg/kg/day in 3 divided doses (children) 1
• Ampicillin-sulbactam + clindamycin: Most commonly used combination in recent pediatric studies (77.2% of cases) 2
• Ceftriaxone + clindamycin: Frequently used alternative, particularly when sinusitis is a predisposing factor 3

Recent real-world data shows clindamycin (72.8%) and ceftriaxone (54.4%) are the most commonly prescribed antibiotics for hospitalized children with preseptal cellulitis 3.

Penicillin Allergy Alternatives

Critical caveat: Most patients reporting penicillin allergy are not truly allergic - only 5-8% of adults and approximately 2% of children with reported penicillin allergy have confirmed allergy 4. The risk decreases significantly if the reaction occurred >1 year ago 4.

For Non-Immediate Hypersensitivity Reactions (Delayed Rash)

Cefazolin is safe and preferred - it has unique R1 and R2 side chains that largely rule out cross-reactivity with penicillins 5. In a case series, 20 of 21 patients (95%) with previous β-lactam reactions tolerated cefazolin without issue 5.

• Adults: Cefazolin 1 g every 8 hours IV
• Children: Cefazolin 50 mg/kg/day in 3 divided doses IV 1

For Immediate Hypersensitivity (Urticaria, Angioedema, Anaphylaxis)

Do NOT use cephalosporins without prior testing. Use alternative agents:

Clindamycin (preferred for documented IgE-mediated allergy):

• Adults: 600 mg every 8 hours IV or 300-450 mg four times daily orally 1
• Children: 25-40 mg/kg/day in 3 divided doses IV or 30-40 mg/kg/day in 3 divided doses orally 1

Important limitation: Clindamycin is bacteriostatic and has potential for inducible resistance in MRSA strains 1. However, it remains an important option, especially in children 1.

Alternative for documented MRSA or treatment failure:

• Vancomycin: 30 mg/kg/day in 2 divided doses IV (adults) or 40 mg/kg/day in 4 divided doses IV (children) 1

Treatment Duration and Monitoring

Duration: 5 days minimum, but extend if infection has not improved within this timeframe 1. Real-world data shows mean treatment duration of 8.4 days with clinical improvement typically by day 5 2.

Factors predicting longer treatment:

• Presence of leukocytosis (mean 9.3 vs 7.8 days without leukocytosis) 2
• Age >5 years (longer time to clinical improvement) 2
• Predisposing factors like sinusitis or odontogenic infection 3, 6

Critical Red Flags Requiring Imaging and Escalation

Order CT scan if:

• Symptoms worsen or fail to improve within 24-48 hours on appropriate antibiotics
• Migratory pattern of swelling (crossing midline or spreading beyond initial site) 7
• Proptosis, ophthalmoplegia, or vision changes suggesting orbital involvement
• Severe systemic toxicity

Common pitfall: Preseptal cellulitis can progress to intracranial complications (subdural empyema) even without orbital involvement, particularly when secondary to sinusitis 7. Migratory eyelid swelling should heighten suspicion for atypical or progressive disease requiring urgent imaging 7.

Adjunctive Measures

• Elevate affected area 1
• Treat predisposing factors (sinusitis, dental infections, skin trauma) 1, 3
• Warm compresses may provide symptomatic relief

Hospitalization Criteria

Admit if:

• Systemic signs of infection (SIRS criteria)
• Age <1 year
• Immunocompromised state
• Failed outpatient therapy
• Concern for orbital or intracranial extension
• Poor adherence anticipated 1

Approximately 42.6% of hospitalized children undergo CT imaging, most commonly revealing preseptal cellulitis (21.3%) or ethmoid sinusitis (10.3%) 3.